top of page
Latest News
Ground-breaking new study from ISAR uncovers the power of asthma tests BEC and FeNO to predict effectiveness of biologic therapies in Severe Asthma
A new real-world research study from ISAR, the International Severe Asthma Registry , reveals the strength of the asthma tests...
May 8, 20242 min read
New evidence reveals the power of biologics to improve severe asthma outcomes in patients with T2 comorbidities
ISAR ’s new publication "Association between T2-related co-morbidities and effectiveness of biologics in severe asthma” to the highly...
Mar 14, 20241 min read
Latest ISAR research reveals the significant impact of pre-existing health on response to treatment with biologics in Severe Asthma
Important progress has been gained in the journey towards understanding response to biologic therapy in severe asthma through the...
Feb 22, 20242 min read
Opportunities to Optimize High-risk COPD Management Persist in US Primary Care
OPRI and affiliate organization, OPC announced the results of the latest observational study for CONQUEST
Aug 1, 20233 min read
Biologics dramatically reduce steroid requirements and exacerbation rates in severe asthma patients
The International Severe Asthma Registry (ISAR)’s newest study has found that keeping severe asthma patients on high oral corticosteroid...
Jul 25, 20231 min read
bottom of page